123 related articles for article (PubMed ID: 23942919)
1. Overcoming obstacles in accessing unfunded oral chemotherapy: physician experience and challenges.
Han D; Trinkaus M; Hogeveen S; Mamdani M; Berry SR; Jang RW; Hoch JS; Simmons C
J Oncol Pract; 2013 Jul; 9(4):188-93. PubMed ID: 23942919
[TBL] [Abstract][Full Text] [Related]
2. Current Attitudes toward Unfunded Cancer Therapies among Canadian Medical Oncologists.
Wong SK; Gondara L; Gill S
Curr Oncol; 2021 Nov; 28(6):4748-4755. PubMed ID: 34898584
[TBL] [Abstract][Full Text] [Related]
3. Variation and consternation: access to unfunded cancer drugs in Canada.
Berry SR; Evans WK; Strevel EL; Bell CM
J Oncol Pract; 2012 Jan; 8(1):35-9. PubMed ID: 22548009
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal chemotherapy for advanced epithelial ovarian cancer: A Canadian perspective.
Alhayki M; Hopkins L; LE T; Fung Kee Fung M
Int J Gynecol Cancer; 2006; 16(5):1761-5. PubMed ID: 17009968
[TBL] [Abstract][Full Text] [Related]
5. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ
J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077
[TBL] [Abstract][Full Text] [Related]
6. Less than ideal: how oncologists practice with limited drug access.
Chan KK; Wong B; Siu LL; Straus SE; Chang J; Berry SR
J Oncol Pract; 2012 May; 8(3):190-5. PubMed ID: 22942815
[TBL] [Abstract][Full Text] [Related]
7. Canadian oncologists and clinical practice guidelines: a national survey of attitudes and reported use. Provincial Lung Disease Site Group of Cancer Care Ontario.
Graham ID; Evans WK; Logan D; O'Connor A; Palda V; McAuley L; Brouwers M; Harrison MB
Oncology; 2000 Nov; 59(4):283-90. PubMed ID: 11096339
[TBL] [Abstract][Full Text] [Related]
8. Recommending Unfunded Innovative Cancer Therapies: Ethical vs. Clinical Perspectives among Oncologists on a Public Healthcare System-A Mixed-Methods Study.
Bashkin O; Dopelt K; Asna N; Davidovitch N
Curr Oncol; 2021 Aug; 28(4):2902-2913. PubMed ID: 34436020
[TBL] [Abstract][Full Text] [Related]
9. National survey on prophylactic cranial irradiation: differences in practice patterns between medical and radiation oncologists.
Cmelak AJ; Choy H; Shyr Y; Mohr P; Glantz MJ; Johnson DH
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):157-62. PubMed ID: 10219809
[TBL] [Abstract][Full Text] [Related]
10. Barriers to participation in clinical trials: a physician survey.
Mahmud A; Zalay O; Springer A; Arts K; Eisenhauer E
Curr Oncol; 2018 Apr; 25(2):119-125. PubMed ID: 29719427
[TBL] [Abstract][Full Text] [Related]
11. Generalists and oncologists show similar care practices and outcomes for hospitalized late-stage cancer patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks for Treatment.
Rose JH; O'Toole EE; Dawson NV; Thomas C; Connors AF; Wenger N; Phillips RS; Hamel MB; Reding DT; Cohen HJ; Lynn J
Med Care; 2000 Nov; 38(11):1103-18. PubMed ID: 11078051
[TBL] [Abstract][Full Text] [Related]
12. Awareness, understanding, attitude and barriers toward prescribing modern cancer immunotherapies in the Arabian Gulf countries.
Al-Shamsi HO; Tashkandi E; Bukhari N; Al Farsi A; Alnajjar A; Alhuraiji A; Foheidi M; Sagheir A; Bin Thani K; Al Bahrani B; Alrawi S
Gulf J Oncolog; 2018 May; 1(27):45-51. PubMed ID: 30145551
[TBL] [Abstract][Full Text] [Related]
13. Oncologists' opinions towards recommending exercise to patients with cancer: a Canadian national survey.
Jones LW; Courneya KS; Peddle C; Mackey JR
Support Care Cancer; 2005 Nov; 13(11):929-37. PubMed ID: 15809835
[TBL] [Abstract][Full Text] [Related]
14. Perspectives and practical applications of medical oncologists on defensive medicine (SYSIPHUS study): a study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).
Tanriverdi O; Cay-Senler F; Yavuzsen T; Turhal S; Akman T; Komurcu S; Cehreli R; Ozyilkan O
Med Oncol; 2015 Apr; 32(4):106. PubMed ID: 25750041
[TBL] [Abstract][Full Text] [Related]
15. Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States.
Virgo KS; Lerro CC; Klabunde CN; Earle C; Ganz PA
J Clin Oncol; 2013 Jun; 31(18):2322-36. PubMed ID: 23690429
[TBL] [Abstract][Full Text] [Related]
16. Improving Physician Knowledge: A Necessary but Not Sufficient Requirement of Improving Intrauterine Contraception Access in Canada.
Howatt K; Binette A; Pudwell J; Waddington A
J Obstet Gynaecol Can; 2019 Aug; 41(8):1115-1124. PubMed ID: 30803875
[TBL] [Abstract][Full Text] [Related]
17. Medical oncologists' perceptions of financial incentives in cancer care.
Malin JL; Weeks JC; Potosky AL; Hornbrook MC; Keating NL
J Clin Oncol; 2013 Feb; 31(5):530-5. PubMed ID: 23269996
[TBL] [Abstract][Full Text] [Related]
18. Oncologists and primary care physicians' attitudes toward pain control and morphine prescribing in France.
Larue F; Colleau SM; Fontaine A; Brasseur L
Cancer; 1995 Dec; 76(11):2375-82. PubMed ID: 8635046
[TBL] [Abstract][Full Text] [Related]
19. The effect of priority setting decisions for new cancer drugs on medical oncologists' practice in Ontario: a qualitative study.
Berry SR; Hubay S; Soibelman H; Martin DK
BMC Health Serv Res; 2007 Nov; 7():193. PubMed ID: 18042302
[TBL] [Abstract][Full Text] [Related]
20. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.
Dudani S; Leighl NB; Ho C; Pantarotto JR; Zhu X; Zhang T; Wheatley-Price P
Lung Cancer; 2016 Apr; 94():74-80. PubMed ID: 26973210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
